Dr. Stephen Ash, MD

NPI: 1417926940
Total Payments
$35,698
2024 Payments
$314.01
Companies
12
Transactions
64
Medicare Patients
274
Medicare Billing
$45,613

Payment Breakdown by Category

Consulting$29,683 (83.1%)
Travel$2,703 (7.6%)
Food & Beverage$2,220 (6.2%)
Research$1,080 (3.0%)
Education$12.23 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $29,683 8 83.1%
Travel and Lodging $2,703 12 7.6%
Food and Beverage $2,220 40 6.2%
Unspecified $1,080 2 3.0%
Education $12.23 2 0.0%

Payments by Type

General
$34,618
62 transactions
Research
$1,080
2 transactions

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $21,312 38 $0 (2021)
Bard Peripheral Vascular, Inc. $7,844 7 $0 (2018)
Merit Medical Systems Inc $3,619 5 $0 (2018)
Covidien LP $1,520 2 $0 (2020)
Medtronic, Inc. $700.00 1 $0 (2018)
AKEBIA THERAPEUTICS INC $219.86 2 $0 (2024)
BAXTER HEALTHCARE $124.71 1 $0 (2018)
Fresenius USA Marketing, Inc. $96.99 3 $0 (2022)
Novartis Pharmaceuticals Corporation $94.15 1 $0 (2024)
Amgen Inc. $74.67 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $314.01 3 AKEBIA THERAPEUTICS INC ($219.86)
2022 $65.05 2 Fresenius USA Marketing, Inc. ($65.05)
2021 $284.92 4 AstraZeneca Pharmaceuticals LP ($222.08)
2020 $4,724 10 AstraZeneca Pharmaceuticals LP ($3,584)
2019 $17,535 24 AstraZeneca Pharmaceuticals LP ($17,145)
2018 $5,082 15 Merit Medical Systems Inc ($3,619)
2017 $7,693 6 Bard Peripheral Vascular, Inc. ($7,619)

All Payment Transactions

64 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/23/2024 AKEBIA THERAPEUTICS INC Auryxia (Drug), Vafseo Food and Beverage In-kind items and services $125.00 General
Category: Nephrology
08/14/2024 AKEBIA THERAPEUTICS INC Auryxia (Drug), Vafseo Food and Beverage In-kind items and services $94.86 General
Category: Nephrology
02/14/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $94.15 General
06/22/2022 Fresenius USA Marketing, Inc. Velphoro (Drug), OPTIFLUX Food and Beverage In-kind items and services $26.44 General
Category: Phosphate binder for ESRD
03/01/2022 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $38.61 General
Category: Phosphate binder for ESRD
08/19/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $102.55 General
07/07/2021 Abbott Laboratories HeartMate 3 Left Ventricular Assist Device (Device) Food and Beverage In-kind items and services $62.84 General
Category: Heart Failure
06/15/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $102.24 General
04/21/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $17.29 General
Category: Cardiovascular and Metabolism
12/13/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Consulting Fee Cash or cash equivalent $3,334.00 General
Category: Cardiovascular and Metabolism
11/19/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $20.10 General
Category: Cardiovascular and Metabolism
11/19/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Education In-kind items and services $5.00 General
Category: Cardiovascular and Metabolism
09/30/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $103.90 General
Category: Cardiovascular and Metabolism
09/16/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $21.61 General
Category: Cardiovascular and Metabolism
07/29/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $7.41 General
Category: Cardiovascular and Metabolism
03/10/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $23.20 General
Category: Cardiovascular and Metabolism
02/18/2020 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $26.50 General
02/09/2020 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $42.16 General
01/23/2020 Covidien LP Chameleon (Device) Consulting Fee Cash or cash equivalent $1,140.00 General
Category: Percutaneous Transluminal Angioplasty (PTA) Balloons
11/08/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $21.64 General
Category: Cardiovascular and Metabolism
09/05/2019 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $103.89 General
06/09/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Consulting Fee Cash or cash equivalent $5,850.00 General
Category: Cardiovascular and Metabolism
05/17/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Travel and Lodging In-kind items and services $433.51 General
Category: Cardiovascular and Metabolism
05/17/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Travel and Lodging In-kind items and services $433.51 General
Category: Cardiovascular and Metabolism
05/17/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Travel and Lodging In-kind items and services $237.00 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 3 69 154 $38,470 $12,391
2021 2 123 244 $56,440 $20,921
2020 2 82 134 $30,988 $12,302
Total Patients
274
Total Services
532
Medicare Billing
$45,613
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 39 112 $23,632 $8,460 35.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 18 22 $7,238 $2,822 39.0%
90935 Hemodialysis procedure with physician evaluation Facility 2022 12 20 $7,600 $1,108 14.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 82 202 $42,622 $14,956 35.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 41 42 $13,818 $5,964 43.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 59 111 $23,421 $8,899 38.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 23 23 $7,567 $3,403 45.0%

About Dr. Stephen Ash, MD

Dr. Stephen Ash, MD is a Nephrology healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417926940.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Ash, MD has received a total of $35,698 in payments from pharmaceutical and medical device companies, with $314.01 received in 2024. These payments were reported across 64 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($29,683).

As a Medicare-enrolled provider, Ash has provided services to 274 Medicare beneficiaries, totaling 532 services with total Medicare billing of $45,613. Data is available for 3 years (2020–2022), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Lafayette, IN
  • Active Since 03/16/2006
  • Last Updated 01/28/2021
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1417926940

Products in Payments

  • LOKELMA (Drug) $20,470
  • Chameleon (Device) $1,140
  • Auryxia (Drug) $219.86
  • Renal - Sharesource (Device) $124.71
  • BPV-Glidepath Catheter (Device) $95.80
  • Parsabiv (Biological) $74.67
  • Velphoro (Drug) $65.05
  • HeartMate 3 Left Ventricular Assist Device (Device) $62.84
  • Not Product Related (Medical Supply) $31.94
  • BRILINTA (Drug) $20.22
  • FARXIGA (Drug) $5.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Lafayette